-
Summary
Therapeutic targeting of deregulated genetic network of insulin resistance may open a new hope for treating T2DM that is very common in Egypt. We will perform a computational analysis to retrieve lncRNA-associated ceRNAs involved in T2DM , validate in patients’ and cell line. We will evaluate gene editing as a potential therapeutic strategy to modulate the expression of deregulated network in T2DM. Meanwhile, we will transfer gene editing technology to junior researchers
-
Achievements
-
List of Publications from the Project
-
Partners
-
Project Members
-
Project Leaders
-
Project PI
-
Faculty
Faculty of Medicine
-
Research Group
-
Funding Agency
Academy of Scientific Research & Technology (ASRT)
-
Funding Program
JESOR
-
Start Date
2018-10-18
-
End Date
2021-03-09
-
Sustainable Development Goals (SDGs)
- 3: Good Health and Well-being
-
Project website